green
fluoresc
protein
gfp
gene
ligat
lactobacillu
reuterispecif
nisininduc
expressionsecret
vector
pni
gener
pniesgfp
vector
capabl
secret
clone
gene
gfpfusion
protein
fluoresc
activ
develop
system
live
vehicl
carri
heatstabl
enterotoxin
st
heatlabil
enterotoxin
b
lt
b
enterotoxigen
escherichia
coli
etec
recombin
stlt
b
dna
fragment
clone
pniesgfp
result
l
reuteripniesgfp
stlt
b
system
found
possess
capabl
adher
mice
gut
secret
gfp
stlt
b
product
pgcell
induc
noninduc
condit
respect
analysi
gfp
stlt
b
product
confirm
gangliosidebind
abil
lt
b
antigen
rel
freedom
stassoci
toxic
make
suitabl
use
oral
vaccin
mice
oral
inocul
l
reuteripniesgfp
stlt
b
cultur
mice
elicit
signific
p
serum
igg
mucos
iga
antibodi
stlt
b
antigen
immun
mice
subsequ
challeng
etec
show
full
protect
fluid
influx
respons
gut
first
report
use
l
reuteri
vaccin
carrier
induc
complet
immunolog
protect
etec
lactobacillu
reuteri
frequent
found
gastrointestin
tract
human
anim
discov
advantag
make
suitabl
use
probiot
chung
et
al
seeger
tubeliu
et
al
develop
microb
probiot
effect
live
vehicl
carri
immunolog
molecul
would
provid
gastrointestin
tract
extra
medic
benefit
implement
goal
l
reuteri
along
mani
lactobacillu
speci
alreadi
appli
probiot
field
intens
explor
possibl
role
vaccin
carrier
last
decad
howev
knowledg
four
l
reuteri
speci
lactobacillu
acidophilu
chu
et
al
l
casei
zeger
et
al
shaw
et
al
ho
et
al
l
johnsonii
scheppler
et
al
l
plantarum
shaw
et
al
grangett
et
al
reveneau
et
al
corthesi
et
al
produc
foreign
antigen
ie
ureas
b
proteinas
b
tetanu
toxin
fragment
c
coronaviru
glycoprotein
elicit
specif
immun
respons
mucos
membran
system
one
reason
small
number
may
limit
sourc
expressionsecret
vector
esv
frequent
speciesspecif
difficult
adapt
lactobacillu
reuteri
speci
therefor
construct
new
esv
nearli
inevit
lactobacillu
reuteri
speci
interest
chosen
live
vehicl
develop
given
consider
phylogen
distanc
exist
among
lactobacillu
reuteri
speci
reveneau
et
al
usual
vari
greatli
efficaci
transcript
translat
secret
signal
grangett
et
al
scheppler
et
al
seeger
broad
hostspectrum
esv
function
mani
l
reuteri
speci
seem
unlik
develop
near
featur
accordingli
l
reuterispecif
nisininduc
esv
pni
construct
found
possess
advantag
includ
high
secret
effici
high
constitut
es
activ
also
satisfactori
induc
capac
appropri
use
l
reuteri
vaccin
vector
enterotoxigen
escherichia
coli
etec
respons
sizabl
fraction
morbid
mortal
burden
diarrheal
diseas
suffer
young
children
develop
countri
guzmanverduzco
kupersztoch
virul
etec
directli
relat
product
heatlabil
lt
andor
heatstabl
st
toxin
alter
hydrosalin
balanc
intestin
mucosa
knowledg
licens
vaccin
avail
etec
thu
far
appar
effort
still
requir
import
goal
realiz
fusion
st
lt
enterotoxin
b
lt
b
togeth
success
evok
high
titer
neutral
antibodi
effici
st
lt
b
clement
addit
recombin
stlt
b
dna
templat
guzmanverduzco
kupersztoch
immedi
avail
bear
mind
stlt
b
gene
encod
acid
st
polypeptid
includ
acid
activ
st
enterotoxin
acid
lt
b
polypeptid
devoid
origin
leader
peptid
pcramplifi
test
potenti
role
subunit
vaccin
newli
construct
l
reuteri
pni
system
studi
pni
upgrad
pniesgfp
abl
express
secret
clone
stlt
b
gene
gfp
stlt
b
fusion
protein
fluoresc
activ
l
reuteripniesgfp
system
secret
gfp
stlt
b
protein
character
evalu
suitabl
use
gastrointestin
tract
mice
mice
immun
antibodi
titer
igg
iga
detect
protect
test
also
includ
report
bacteri
strain
recombin
plasmid
use
studi
list
tabl
experi
perform
strain
l
reuteri
l
reuteri
l
reuteri
lactobacillu
reuteri
prototyp
origin
human
intestin
kandler
et
al
wherea
l
reuteri
isol
mice
cecum
clone
step
done
e
coli
strain
new
england
biolab
grown
lb
medium
difco
aerat
lactobacillu
reuteri
strain
cultur
buffer
mr
broth
difco
contain
potassium
phosphat
ph
without
shake
requir
erythromycin
ad
cultur
medium
final
concentr
mg
ml
recombin
l
reuteri
rl
reuteri
e
coli
strain
respect
plasmid
e
coli
extract
use
alkalin
lysi
method
l
reuteri
plasmid
isol
describ
chassi
giuffrida
restrict
endonucleas
dna
ligas
taq
polymeras
purchas
new
england
biolab
use
accord
manufactur
recommend
electropor
l
reuteri
e
coli
perform
describ
lin
chung
construct
scheme
pniesgfp
stlt
b
shown
fig
expressionsecret
vector
pni
construct
previous
gfp
gene
bp
pcramplifi
qbiogen
use
oligonucleotid
tgactagtgctagcaaagga
ga
gtcagaattcgcgaagcttgct
restrict
site
underlin
primer
pcr
product
gfp
gene
treatment
speiecori
ligat
speiecoridigest
pni
creat
plasmid
pniesgfp
fig
subsequ
stlt
b
gene
bp
produc
pcramplif
guzmanverduzco
kupersztoch
use
primer
set
stf
lt
b
r
ctagaattcttttaag
digest
bamhiecori
insert
correspond
site
pniesgfp
gener
pniesgfp
stlt
b
fig
standard
pcr
carri
autom
thermal
cycler
perkinelm
amplif
perform
ng
plasmid
dna
follow
condit
min
follow
cycl
consist
final
step
min
produc
larg
amount
stlt
b
protein
e
coli
bamhiecori
stlt
b
fragment
clone
express
vector
novagen
creat
petstlt
b
integr
dna
sequenc
everi
step
clone
process
mention
confirm
sequenc
analysi
fluoresc
activ
l
reuteripniesgfp
stlt
b
recombin
l
reuteri
rl
reuteri
cell
directli
observ
eye
use
epifluoresc
microscop
olympu
model
fit
fitc
filter
set
activ
express
gfp
fusion
protein
perform
describ
overnight
rl
reuteri
cultur
use
inocul
fresh
mr
media
dilut
incub
h
cultur
ad
induc
cultur
noninduc
cultur
nisin
sigma
final
concentr
ng
ml
allow
grow
h
adjust
addit
mr
broth
od
nm
c
cfu
ml
ml
odadjust
cultur
centrifug
supernat
concentr
volum
amicon
concentr
millipor
use
latterli
supernat
fraction
protein
analysi
cell
pellet
wash
twice
resuspend
ml
lysi
buffer
ml
mmtrishcl
buffer
contain
mg
lysozym
mutanolysin
incub
h
produc
protoplast
sonic
protoplast
perform
ultrason
homogen
labson
sartoriu
bbi
system
clear
lysat
obtain
centrifug
use
intracellular
fraction
protein
analysi
visual
protein
lysat
supernat
protein
concentr
sampl
analyz
use
biorad
protein
assay
kit
mix
well
equal
amount
sampl
buffer
subject
western
blot
analysi
et
al
polyclon
rabbit
antiserum
gfp
invitrogen
alkalin
phosphataseconjug
goat
antirabbit
igg
antibodi
sigma
use
immunoblot
target
protein
detect
quantif
protein
gel
perform
compar
signal
scan
target
protein
purifi
gfp
stlt
b
standard
use
alphaimag
imageanalyz
system
alpha
innotech
comput
program
alphaimag
tm
version
describ
gangliosid
bind
activ
gfp
stlt
b
protein
examin
follow
procedur
describ
slo
et
al
briefli
microtit
plate
precoat
per
well
ng
mix
gangliosid
sigma
carbonatebicarbon
coat
buffer
ph
load
ml
concentr
supernat
sampl
follow
addit
rabbit
antilt
b
antiserum
immunolog
consult
laboratori
pnitrophenyl
phosphat
sigma
absorb
measur
nm
suckl
mous
assay
descri
giannella
slight
modif
perform
determin
st
toxic
gfp
stlt
b
protein
brief
solut
contain
mg
ml
st
prepar
dissolv
dilut
purifi
st
u
mg
sigma
phosphatebuff
salin
pb
contain
bovin
serum
albumin
trypan
blue
dye
process
also
perform
prepar
mg
ml
gfp
stlt
b
solut
concentr
rl
reuteri
cultur
supernat
gfp
stlt
b
concentr
estim
advanc
use
alphaimag
imageanalyz
system
mention
assay
st
toxic
mice
five
group
infant
spf
balbc
mice
day
old
five
mice
per
group
purchas
nation
laboratori
anim
center
nlac
taipei
taiwan
hous
cage
free
access
water
feed
approv
local
veterinari
offic
intragastr
inocul
group
ml
one
aforement
concentr
st
gfp
stlt
b
solut
per
mous
h
anim
sacrif
dissect
data
collect
show
blue
color
stomach
evid
success
inocul
solut
stomach
entir
intestin
remain
carcass
weigh
separ
weight
ratio
gut
remain
carcass
gc
ratio
calcul
two
group
mice
five
mice
per
group
respect
administ
oral
rl
reuteri
rl
reuteri
dose
cfu
per
mous
fresh
fece
five
mice
group
collect
day
everi
day
administr
day
crush
togeth
steril
pb
obtain
pool
sampl
mg
ml
fecal
suspens
group
serial
dilut
made
persist
estim
triplic
plate
ml
appropri
dilut
onto
lactobacillu
reuteriselect
rogosa
agar
merck
contain
mg
ml
erythromycin
count
visibl
coloni
h
anaerob
incub
ten
randomli
select
coloni
per
plate
pick
examin
fluoresc
activ
flu
epifluoresc
microscop
describ
percentag
flu
coloni
obtain
use
index
adjust
fecal
cfu
valu
cfu
mg
fece
calcul
em
r
coloni
spf
balbc
mice
age
week
five
mice
per
group
hous
cage
day
prior
commenc
experi
prepar
rl
reuteri
mice
immun
larg
volum
mr
media
inocul
overnight
cultur
concentr
nisin
ad
cultur
incub
h
cultur
incub
anoth
h
harvest
centrifug
g
min
obtain
pellet
immedi
resuspend
administr
buffer
sodium
bicarbon
casein
hydrolys
glucos
robinson
et
al
adjust
od
nm
read
reach
concentr
cfu
ml
mice
intragastr
inocul
freshli
prepar
cell
suspens
daili
dose
ml
per
mous
day
repeat
three
time
one
prime
two
boost
interv
repeat
ten
day
administr
individu
sera
fresh
fecal
pellet
collect
treat
describ
robinson
et
al
vaccin
experi
carri
least
two
separ
occas
result
demonstr
reproduc
stlt
b
protein
extract
iptginduc
e
coli
novagen
transform
petstlt
b
purifi
niaffin
chromatographi
novagen
recommend
manufactur
titer
sera
igg
fecal
iga
antistlt
b
antibodi
determin
enzymelink
immunosorb
assay
elisa
describ
grangett
et
al
briefli
polystyren
microtit
plate
nunc
coat
overnight
mg
purifi
stlt
b
ad
twofold
serial
dilut
serum
fecal
sampl
bound
antibodi
detect
use
alkalin
phosphatas
conjug
goat
antimous
igg
iga
sigma
follow
color
develop
use
pnitrophenyl
phosphat
substrat
absorb
measur
nm
endpoint
titer
defin
highest
dilut
gave
absorb
three
time
higher
background
challeng
procedur
patent
mous
gut
pmg
assay
vivo
enterotoxin
neutral
determin
use
pmg
assay
describ
guidri
et
al
modif
briefli
immun
mice
given
steril
water
contain
mg
streptomycin
per
millilit
ad
libitum
day
fast
h
follow
steril
water
addit
h
prior
challeng
challeng
mice
inocul
intragastr
ml
nahco
solut
alon
conjunct
cfu
live
etec
organ
mice
remain
cage
without
food
water
ad
libitum
h
sacrif
co
inhal
entir
intestin
carcass
weigh
separ
gc
ratio
calcul
anim
result
express
mean
ae
se
mean
sem
statist
signific
evalu
student
ttest
statist
signific
consid
p
shown
fig
promoterless
gfp
gene
clone
l
reuterispecif
expressionsecret
vector
pni
gener
chimer
plasmid
pniesgfp
eight
uniqu
clone
site
immedi
downstream
gfp
gene
lactobacillu
reuteri
transform
pniesgfp
exhibit
intracellular
extracellular
green
fluoresc
activ
fig
indic
gfp
gene
success
clone
regul
express
secret
element
pni
test
function
pniesgfp
express
secret
clone
gene
interest
gfpfusion
product
stlt
b
gene
ligat
bamhiecori
site
translat
infram
fuse
upstream
gfp
gene
result
plasmid
pniesgfp
stlt
b
fig
shown
contain
gfp
stlt
b
dna
fragment
restrict
pcramplif
analysi
supplementari
fig
transform
l
reuteri
l
reuteri
l
reuteri
transfor
carri
pniesgfp
stlt
b
found
exhibit
fluoresc
activ
flu
cytoplasm
cultur
supernat
though
yellow
color
fig
western
blot
analysi
cultur
supernat
detect
presenc
protein
correspond
molecular
mass
matur
gfp
stlt
b
protein
predict
dna
sequenc
fig
confirm
capabl
pniesgfp
express
secret
gfpfusion
protein
fluoresc
activ
character
gfp
stlt
b
fusion
protein
secret
l
reuteri
pniesgfp
stlt
b
rl
reuteri
quantif
secret
gfp
stlt
b
fusion
protein
use
gelprotein
scan
shown
fig
four
hour
inocul
yield
fusion
protein
supernat
nisininduc
rl
reuteri
rl
reuteri
estim
mg
l
fig
respect
wherea
yield
supernat
noninduc
cultur
mg
l
respect
fig
rl
reuteri
concentr
use
analysi
cfu
ml
amount
gfp
stlt
b
pg
secret
per
cell
aforement
group
could
thu
estim
respect
estim
gangliosidebind
abil
gfp
stlt
b
protein
g
elisa
perform
significantli
p
higher
bind
index
ie
optic
absorb
read
compar
neg
control
detect
cultur
supernat
rl
reuteri
strain
fig
demonstr
capabl
gfp
stlt
b
bind
gangliosid
purifi
intestin
epitheli
cell
moreov
antilt
b
use
elisa
test
posit
result
also
confirm
exist
lt
b
antigen
gfp
stlt
b
protein
detect
possibl
st
toxic
remain
fusion
protein
gfp
stlt
b
oral
administ
mice
dose
high
ng
respect
gastrointestin
fluid
influx
respons
measur
gc
ratio
dose
less
posit
threshold
st
toxic
ie
determin
studi
tabl
contrari
found
accomplish
mere
ng
purifi
st
thu
shown
tabl
observ
advers
effect
level
noael
gfp
stlt
b
pmol
calcul
time
greater
purifi
st
pmol
indic
rel
freedom
stassoci
toxic
gfp
stlt
b
protein
stabil
pniesgfp
stlt
b
rl
reuteri
transit
time
rl
reuteri
gastrointestin
tract
analyz
stabil
pniesgfp
stlt
b
rl
reuteri
rl
reuteri
rl
reuteri
grown
mr
ng
pmol
ae
st
ng
u
mg
sigma
amount
toxin
capabl
produc
gc
ratio
swiss
albino
mice
day
old
describ
sigma
product
manual
howev
compar
fluid
influx
observ
experi
use
balbc
mice
day
old
gc
ratio
determin
indic
posit
st
respons
studi
without
erythromycin
analyz
percentag
coloni
still
maintain
plasmidencod
em
r
marker
interv
c
h
shown
fig
coloni
strain
grow
gener
c
h
still
abl
grow
erythromycincontain
media
stabil
index
stage
could
thu
interpret
howev
gener
c
h
stabil
index
strain
declin
significantli
reach
ae
ae
rl
reuteri
rl
reuteri
respect
indic
pniesgfp
stlt
b
better
segreg
stabil
l
reuteri
p
investig
persist
rl
reuteri
gastrointestin
tract
mice
inocul
oral
dose
c
cfu
rl
reuteri
rl
reuteri
larg
amount
rl
reuteri
began
appear
fece
h
administr
fig
although
number
fecal
cfu
time
point
group
significantli
differ
p
ident
fluctuat
pattern
cfu
along
time
cours
observ
group
fluctuat
pattern
includ
two
signific
declin
cfu
day
p
compar
cfu
last
day
respect
substanti
presenc
rl
reuteri
em
r
flu
even
day
administr
fecal
persist
time
excess
h
ident
gastrointestinaladhes
lactic
acid
bacteria
grangett
et
al
strongli
indic
capabl
rl
reuteri
colon
gastrointestin
tract
estim
whether
cfu
count
includ
compar
coloni
em
r
lactic
acid
bacteria
sometim
found
gastrointestin
tract
pig
chicken
human
chin
et
al
delgado
et
al
mathur
singh
still
definit
mice
total
randomli
pick
coloni
plate
repres
group
rl
reuteri
day
experi
subject
fluoresc
activ
flu
analysi
result
confirm
count
cfu
origin
administ
rl
reuteri
em
r
flu
examin
whether
rl
reuteri
system
intragastr
administr
mice
could
induc
local
andor
system
immun
respons
stlt
b
serum
igg
analysi
fig
reveal
rl
reuteri
rl
reuteri
strain
final
boost
elicit
signific
antistlt
b
igg
level
endpoint
titer
respect
p
compar
neg
control
group
l
reuteri
pb
notabl
immun
respons
rl
reuteri
group
rapid
strong
igg
endpoint
titer
detect
three
immun
stage
ie
prime
first
boost
second
boost
fig
significantli
p
higher
correspond
titer
respect
rl
reuteri
group
mucos
immun
respons
analysi
fecal
stlt
b
specif
iga
titer
reveal
although
evid
immun
activ
control
group
detect
signific
stlt
b
specif
iga
titer
final
boost
liter
record
rl
reuteri
rl
reuteri
group
respect
rl
reuteri
demonstr
rapid
significantli
p
higher
iga
titer
rl
reuteri
indic
suitabl
studi
immun
respons
mice
oral
live
vaccin
success
induct
mucos
stlt
b
specif
iga
observ
patent
mous
gut
assay
guidri
et
al
perform
explor
whether
onset
immun
respons
rl
reuteri
group
could
provid
substanti
protect
etec
challeng
preliminari
pmg
test
dose
respons
gc
ratio
cfu
etec
rang
observ
fig
moreov
dose
cfu
live
etec
abl
induc
seriou
gastrointestin
fluid
influx
build
gut
weight
lead
high
gc
ratio
remark
contrast
seen
neg
control
nahco
solut
group
reveal
normal
gastrointestin
tract
gc
ratio
gross
lesion
fluid
accumul
bowel
especi
cecum
consist
previou
observ
richardson
et
al
fig
preliminari
pmg
test
suggest
gc
ratio
posit
threshold
judg
toxic
effect
etec
studi
success
protect
etec
challeng
seen
mice
immun
either
rl
reuteri
rl
reuteri
neither
visual
fluid
respons
gc
ratio
ie
respect
fig
record
contrast
neg
control
group
administ
pb
l
reuteri
strain
display
massiv
fluid
accumul
gc
ratio
significantli
p
higher
posit
threshold
furthermor
group
nonimmun
mice
gavag
nahco
solut
instead
etec
shown
control
group
fig
found
normal
gastrointestin
tract
gc
ratio
indic
none
materi
use
test
except
etec
strain
abl
caus
fluid
accumul
seen
posit
etec
respons
green
fluoresc
protein
aequorea
victoria
advantag
easili
stabli
detect
epifluoresc
microscopi
without
need
ad
substrat
cofactor
demonstr
superior
report
tradit
enzymat
marker
tag
lactic
acid
bacteria
geoffroy
et
al
gori
et
al
studi
gfp
gene
use
construct
l
reuteripniesgfp
stlt
b
rl
reuteri
em
r
flu
system
express
clone
stlt
b
gene
gfp
stlt
b
fusion
protein
exhibit
fluoresc
activ
flu
provid
select
marker
rl
reuteri
speci
bacteria
eukaryot
fungi
protist
natur
resid
individu
digest
tract
cfu
ml
colon
content
usual
reach
lionetti
et
al
lactobacillu
reuteriselect
rogosa
agar
contain
mg
ml
erythromycin
use
mani
similar
fecal
studi
found
grow
unexpect
coloni
morpholog
compar
rl
reuteri
preliminari
test
rl
reuteri
pig
possibl
microorgan
appear
suspect
yeast
em
r
lactic
acid
bacteria
latter
report
emerg
frequent
fece
pig
chicken
human
chin
et
al
delgado
et
al
mathur
singh
definit
mice
circumst
develop
rl
reuteri
doubl
select
marker
would
certainli
provid
better
accuraci
fecal
cfu
estim
fecal
persist
analysi
total
coloni
examin
doubl
select
marker
two
separ
analys
demonstr
freedom
em
r
lactic
acid
bacteria
experiment
mice
also
confirm
accuraci
cfu
data
noteworthi
gfp
demonstr
reliabl
marker
express
flu
consist
test
coloni
easili
observ
use
epifluoresc
microscop
may
indic
possibl
reli
gfp
gene
sole
select
marker
rl
reuteri
otherwis
antibioticresist
gene
allow
use
human
anim
vaccin
carrier
gfp
stlt
b
product
substanc
eventu
present
rl
reuteri
mucos
immun
system
characterist
rel
suitabl
use
anim
studi
need
evalu
first
size
kda
detect
supernat
rl
reuteri
cultur
fig
probe
specif
antigfp
antilt
b
antibodi
correspond
expect
molecular
mass
matur
gfp
stlt
b
protein
indic
fusion
protein
express
secret
success
also
preserv
import
gfp
lt
b
antigen
properti
second
appear
fluoresc
though
yellow
color
signifi
success
express
fold
gfp
two
total
differ
environ
cell
supernat
cytoplasm
kind
color
chang
describ
qbiogen
manual
normal
result
excitationspectrum
shift
caus
interact
two
moieti
fusion
protein
third
receptor
gangliosid
g
intestin
epitheli
cell
bind
abil
properti
natur
possess
lt
b
correl
mucos
immunogen
adjuvant
lt
b
coadminist
antigen
guidri
et
al
significantli
detect
gfp
stlt
b
protein
find
strongli
qualifi
fusion
product
excel
vaccin
candid
final
fusion
product
time
greater
noael
tabl
purifi
st
indic
free
stassoci
toxic
exact
reason
lost
toxic
gfp
stlt
b
fusion
clear
howev
clement
clement
fuse
lt
b
upstream
st
result
fusion
protein
ie
lt
b
st
free
toxic
suggest
toxic
determin
st
mask
upstream
lt
b
moieti
accordingli
ntermin
gfp
gfp
stlt
b
product
may
mask
effect
downstream
st
studi
requir
address
suggest
stringent
induc
success
mucos
immun
respons
amount
durat
antigen
present
mucosa
crucial
reveneau
et
al
seeger
amount
gfp
stlt
b
protein
secret
rl
reuteri
predict
vitro
estim
pg
cell
period
rl
reuteri
induc
nisin
oral
inocul
mice
basal
constitut
amount
pg
cell
produc
manag
grow
gastrointestin
tract
method
avail
detect
antigen
level
deliv
vaccin
carrier
gastrointestin
tract
develop
tissu
section
techniqu
calcul
gfp
stlt
b
amount
flu
intens
underway
tissu
section
techniqu
develop
would
directli
confirm
colon
capabl
rl
reuteri
gastrointestin
tract
studi
indirectli
prove
fecal
persist
time
show
typic
pattern
adhes
microorgan
grangett
et
al
gener
fecal
persist
time
nonadhes
lactic
acid
bacteria
h
oral
inocul
cfu
oozeer
et
al
extra
fecal
persist
day
rl
reuteri
strongli
indic
capabl
colon
gastrointestin
tract
accordingli
gradat
extend
secret
rl
reuteri
fece
fig
might
attribut
period
slough
adher
rl
reuteri
mucos
membran
signific
differ
p
fecal
cfu
mice
strain
rl
reuteri
human
strain
rl
reuteri
time
point
fig
suspect
caus
possibl
less
adhes
capabl
rl
reuteri
caus
inocul
cfu
quickli
excret
within
first
h
would
occur
normal
ingest
mice
cunliffebeam
one
remain
mucos
membran
though
pattern
behavior
rl
reuteri
natur
would
lower
cfu
count
time
point
mani
pathogen
initi
infect
occur
mucosa
lung
intestin
therefor
import
develop
vaccin
induc
mucos
immun
respons
mediat
predominantli
secretori
iga
siga
neutral
pathogen
point
initi
infect
replic
take
place
furthermor
mani
infect
gain
entranc
mucos
surfac
becom
system
vaccin
also
abl
elicit
specif
immun
system
lymphoid
tissu
gener
foreign
antigen
deliv
oral
live
vaccin
carrier
system
abl
elicit
specif
siga
system
serum
igg
shaw
et
al
grangett
et
al
scheppler
et
al
ho
et
al
failur
induc
antibodi
respons
especi
use
lactobacilli
carrier
mainli
attribut
low
concentr
antigen
express
shaw
et
al
seeger
although
factor
includ
bacteria
strain
cellular
locat
antigen
immun
scheme
even
mice
breed
also
found
certain
impact
seeger
rl
reuteri
success
elicit
serum
igg
fecal
iga
oral
applic
rl
reuteri
rl
reuteri
mice
notabl
rapid
substanti
higher
antibodi
respons
seen
latter
group
provid
possibl
reason
observ
inspect
vitro
analys
abl
find
two
obviou
differ
exist
rl
reuteri
rl
reuteri
plasmid
stabil
vaccin
vector
pniesgfp
stlt
b
rl
reuteri
persist
cfu
number
rl
reuteri
gastrointestin
tract
appar
two
differ
eventu
would
lead
higher
level
gfp
stlt
b
antigen
present
gastrointestin
tract
rl
reuteri
therefor
confirm
previou
descript
level
immun
respons
intim
associ
level
antigen
express
oral
vaccin
carrier
seeger
suckl
mous
model
smm
well
explor
found
simpl
rapid
reproduc
assay
st
toxic
giannella
judg
st
toxic
smm
posit
threshold
gc
ratio
determin
giannella
clement
swiss
albino
suckl
mice
respect
balbc
mice
day
old
use
studi
first
time
smm
found
lower
gc
ratio
tabl
ng
st
accord
sigma
suppos
produc
gc
ratio
swiss
albino
mice
oral
inocul
indic
degre
st
fluid
respons
actual
differ
differ
breed
mice
visual
digit
data
therefor
determin
posit
threshold
gc
ratio
balbc
mice
patent
mous
gut
pmg
assay
detect
enterotoxin
neutral
direct
challeng
live
etec
instead
purifi
lt
also
tri
first
time
studi
dose
respons
gc
ratio
cfu
etec
rang
observ
notabl
signific
fluid
accumul
bowel
visibl
sampl
gc
ratio
therefor
determin
posit
threshold
respond
etec
challeng
studi
threshold
prove
fair
criterion
later
enterotoxin
neutral
studi
rl
reuteriimmun
mice
satisfactori
protect
etec
challeng
demonstr
gc
ratio
summari
present
studi
live
oral
etec
vaccin
use
l
reuteri
deliveri
vehicl
present
gfpstlt
b
fusion
antigen
describ
first
time
satisfactori
serum
igg
iga
titer
well
full
protect
etec
challeng
demonstr
mice
immun
rl
reuteri
materi
avail
part
onlin
articl
http
link
take
articl
abstract
pleas
note
blackwel
publish
respons
content
function
supplementari
materi
suppli
author
queri
miss
materi
direct
correspond
author
articl
